A review of the literature was conducted to examine the clinical effectiveness of inhaled GSH as a treatment for various pulmonary diseases and respiratory-related conditions. This report also ...
Inhalers may be prescribed to people who have ... According to Elaine Fajardo, MD, Medical Director for Respiratory Therapy and Pulmonologist at Yale Medicine, and Assistant Professor at Yale ...
In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly ...
Alveolus Bio is pioneering inhaled delivery of live biotherapeutic products (LBPs) to reduce inflammation in patients with lung diseases. Built on science from a top US respiratory center ...
Respiratory Inhalers Market is estimated to valued at USD 33.11 Bn in 2024 and expected to reach USD 49.10 Bn by 2031, exhibiting CAGR of 5.8% from 2024-2031 BURLINGAME, CA, UNITED STATES ...
At our hospital, preterm infants with severe hypoxic respiratory failure may be treated with iNO as a rescue therapy (that is, those who remain hypoxic following treatment with ventilation and ...